Pierre Triozzi to Antineoplastic Agents, Alkylating
This is a "connection" page, showing publications Pierre Triozzi has written about Antineoplastic Agents, Alkylating.
Connection Strength
0.257
-
Binkley E, Triozzi PL, Rybicki L, Achberger S, Aldrich W, Singh A. A prospective trial of adjuvant therapy for high-risk uveal melanoma: assessing 5-year survival outcomes. Br J Ophthalmol. 2020 04; 104(4):524-528.
Score: 0.174
-
Triozzi PL, Aldrich W, Dombos C. Differential effects of imatinib mesylate against uveal melanoma in vitro and in vivo. Melanoma Res. 2008 Dec; 18(6):420-30.
Score: 0.083